Statements in which the resource exists as a subject.
PredicateObject
rdf:type
lifeskim:mentions
pubmed:issue
7297
pubmed:dateCreated
2010-6-1
pubmed:abstractText
In development, tissue regeneration or certain diseases, angiogenic growth leads to the expansion of blood vessels and the lymphatic vasculature. This involves endothelial cell proliferation as well as angiogenic sprouting, in which a subset of cells, termed tip cells, acquires motile, invasive behaviour and extends filopodial protrusions. Although it is already appreciated that angiogenesis is triggered by tissue-derived signals, such as vascular endothelial growth factor (VEGF) family growth factors, the resulting signalling processes in endothelial cells are only partly understood. Here we show with genetic experiments in mouse and zebrafish that ephrin-B2, a transmembrane ligand for Eph receptor tyrosine kinases, promotes sprouting behaviour and motility in the angiogenic endothelium. We link this pro-angiogenic function to a crucial role of ephrin-B2 in the VEGF signalling pathway, which we have studied in detail for VEGFR3, the receptor for VEGF-C. In the absence of ephrin-B2, the internalization of VEGFR3 in cultured cells and mutant mice is defective, which compromises downstream signal transduction by the small GTPase Rac1, Akt and the mitogen-activated protein kinase Erk. Our results show that full VEGFR3 signalling is coupled to receptor internalization. Ephrin-B2 is a key regulator of this process and thereby controls angiogenic and lymphangiogenic growth.
pubmed:grant
pubmed:commentsCorrections
pubmed:language
eng
pubmed:journal
pubmed:citationSubset
IM
pubmed:chemical
pubmed:status
MEDLINE
pubmed:month
May
pubmed:issn
1476-4687
pubmed:author
pubmed:issnType
Electronic
pubmed:day
27
pubmed:volume
465
pubmed:owner
NLM
pubmed:authorsComplete
Y
pubmed:pagination
483-6
pubmed:meshHeading
pubmed-meshheading:20445537-Animals, pubmed-meshheading:20445537-Cells, Cultured, pubmed-meshheading:20445537-Embryo, Mammalian, pubmed-meshheading:20445537-Embryo Loss, pubmed-meshheading:20445537-Endocytosis, pubmed-meshheading:20445537-Endothelial Cells, pubmed-meshheading:20445537-Ephrin-B2, pubmed-meshheading:20445537-Extracellular Signal-Regulated MAP Kinases, pubmed-meshheading:20445537-Female, pubmed-meshheading:20445537-Humans, pubmed-meshheading:20445537-Lymphangiogenesis, pubmed-meshheading:20445537-Lymphatic Vessels, pubmed-meshheading:20445537-Mice, pubmed-meshheading:20445537-Mice, Transgenic, pubmed-meshheading:20445537-Neovascularization, Physiologic, pubmed-meshheading:20445537-Neuropeptides, pubmed-meshheading:20445537-Pregnancy, pubmed-meshheading:20445537-Proto-Oncogene Proteins c-akt, pubmed-meshheading:20445537-Receptor, EphB4, pubmed-meshheading:20445537-Signal Transduction, pubmed-meshheading:20445537-Vascular Endothelial Growth Factor C, pubmed-meshheading:20445537-Vascular Endothelial Growth Factor Receptor-3, pubmed-meshheading:20445537-Zebrafish, pubmed-meshheading:20445537-rac GTP-Binding Proteins
pubmed:year
2010
pubmed:articleTitle
Ephrin-B2 controls VEGF-induced angiogenesis and lymphangiogenesis.
pubmed:affiliation
Vascular Development Laboratory, Cancer Research UK London Research Institute, London WC2A 3PX, UK.
pubmed:publicationType
Journal Article, Research Support, Non-U.S. Gov't